While it is not possible to compare antibody levels measured in this trial with those seen in trials of other AMA1 vaccines, based on the relative fold - rise and duration of antibody
responses this profile compares favorably with much lower and shorter - lived increases in antibody levels observed in Malian children immunized with AMA1 - C1, an AMA1 vaccine adjuvanted with aluminum hydroxide [19], which provided no
measurable protection in a recently
reported Phase 2 trial at another site in Mali.
In
response to our
reporting, school board members and district officials have vigorously defended their numbers, arguing the loss of students to charter schools had no
measurable impact on the district's graduation rate.